Sign in
4

Changes in Ownership

ANI PHARMACEUTICALS INC Filed Acc 0001871002-23-000006

SVP - CORP. DEV. & STRATEGY sold 20,000 shares at $64.70 ($1,294,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Gassert Chad SVP - CORP. DEV. & STRATEGY 2023-09-01 Sale 10b5-1 −20,000 $64.70 $1,294,000 313,226 I
Open-market sales · 20,000 sh · avg $64.70 · $1,294,000
Loading xslF345X05/wk-form4_1693947949.xml…